AI Verdict
EVGN has stronger fundamentals based on our AI analysis.
EVMN vs EVGN Fundamental Comparison
| Metric | EVMN | EVGN |
|---|---|---|
| Revenue | $13.0M | N/A |
| Net Income | $-68.9M | N/A |
| Net Margin | -529.8% | N/A |
| ROE | -33.5% | N/A |
| ROA | -30.6% | N/A |
| Current Ratio | 8.57x | N/A |
| Debt/Equity | 0.00x | N/A |
| EPS | $-11.22 | N/A |
Green = Better metric | Red = Weaker metric
You Might Also Compare
EVMN vs EVGN: Frequently Asked Questions
Is EVMN or EVGN a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), EVGN has stronger fundamentals. EVMN is rated STRONG SELL (92% confidence) while EVGN is rated SELL (85% confidence). This is not investment advice.
How does EVMN compare to EVGN fundamentally?
Evommune, Inc. has ROE of -33.5% vs Evogene Ltd.'s N/A. Net margins are -529.8% vs N/A respectively.
Which stock pays higher dividends, EVMN or EVGN?
EVMN has a dividend yield of N/A or no dividend while EVGN has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in EVMN or EVGN for long term?
For long-term investing, consider that EVMN has STRONG SELL rating with 92% confidence, while EVGN has SELL rating with 85% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about EVMN vs EVGN?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For EVMN vs EVGN, the AI consensus favors EVGN based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.